Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Crawford

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Micropublication Biology|August 16, 2023
Mutations in the NXF-1:NXT-1 mRNA export complex affect gene-expression driven by the <i>hsp-16.41</i> promoterMichael W Crawford, Galen Posch, Jerôme Cattin-Ortolá, et al.
The American Journal of the Medical Sciences|November 28, 2025
Update on emerging and re-emerging vector-borne diseasesCourtney A Micheletti, Michael W Crawford, William B Messer, et al.
Elife|December 11, 2023
Allelic strengths of encephalopathy-associated <i>UBA5</i> variants correlate between in vivo and in vitro assaysXueyang Pan, Albert N Alvarez, Mengqi Ma, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Allelic strengths of encephalopathy-associated <i>UBA5</i> variants correlate between <i>in vivo</i> and <i>in vitro</i> assaysXueyang Pan, Albert N Alvarez, Mengqi Ma, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
NPJ Vaccines|July 16, 2025
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Micropublication Biology|August 16, 2023
Mutations in the NXF-1:NXT-1 mRNA export complex affect gene-expression driven by the <i>hsp-16.41</i> promoterMichael W Crawford, Galen Posch, Jerôme Cattin-Ortolá, et al.
The American Journal of the Medical Sciences|November 28, 2025
Update on emerging and re-emerging vector-borne diseasesCourtney A Micheletti, Michael W Crawford, William B Messer, et al.
Elife|December 11, 2023
Allelic strengths of encephalopathy-associated <i>UBA5</i> variants correlate between in vivo and in vitro assaysXueyang Pan, Albert N Alvarez, Mengqi Ma, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Allelic strengths of encephalopathy-associated <i>UBA5</i> variants correlate between <i>in vivo</i> and <i>in vitro</i> assaysXueyang Pan, Albert N Alvarez, Mengqi Ma, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
NPJ Vaccines|July 16, 2025
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Pageof 1